Regulatory Affairs CROs in Germany
9 published
9 published CROs match Regulatory Affairs in Germany.
Locations in this set include Germany, United Kingdom, United States, France, Poland, and Spain.
Capabilities that show up most often in this set: Biologics (Other), Small Molecule, Vaccine, Gene Therapy, and Biologics (Monoclonal Antibodies).
Matching companies
Acromion GmbhEuropean full-service CRO supporting clinical development from Phase I to IV and non-interventional studies, with expertise in clinical monitoring, data management, biostatistics, medical writing, and regulatory affairs.
ClarentaClarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.
ICON plcICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
MedpaceFull-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
NuvisanFull-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.
Premier ResearchPremier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
PrimeVigilancePharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.
TFS HealthScienceGlobal mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
Velocity Clinical ResearchIntegrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.
Markdown mirror: /services/regulatory-affairs/germany.md